John G. Bauman

Person

El Sobrante, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Drugs and compositions for the treatment of ocular disorders
- Patent number 11,548,861
- Issue date Jan 10, 2023
- Graybug Vision, Inc.
- Ming Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 10,485,876
- Issue date Nov 26, 2019
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 10,159,747
- Issue date Dec 25, 2018
- Graybug Visioon, Inc.
- Jeffrey L. Cleland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 10,117,950
- Issue date Nov 6, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 10,111,964
- Issue date Oct 30, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 10,098,965
- Issue date Oct 16, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 9,956,302
- Issue date May 1, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for the treatment of ocular disorders
- Patent number 9,808,531
- Issue date Nov 7, 2017
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Intermediates for the preparation of lipoxin A4 analogs
- Patent number 7,928,255
- Issue date Apr 19, 2011
- Bayer Schering Pharma Aktiengesellschaft
- John G. Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 7,268,140
- Issue date Sep 11, 2007
- Schering AG
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lipoxin A4 analogs
- Patent number 7,223,798
- Issue date May 29, 2007
- Schering Aktiengesellschaft
- John G Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,977,258
- Issue date Dec 20, 2005
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,972,290
- Issue date Dec 6, 2005
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lipoxin A4 analogs
- Patent number 6,831,186
- Issue date Dec 14, 2004
- Schering Aktiengesellschft
- John G Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,573,266
- Issue date Jun 3, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,555,537
- Issue date Apr 29, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,541,476
- Issue date Apr 1, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,534,509
- Issue date Mar 18, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,207,665
- Issue date Mar 27, 2001
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the production of 2-fluoropurine derivatives
- Patent number 5,696,255
- Issue date Dec 9, 1997
- Schering Aktiengesellschaft
- Helmut Vorbruggen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of fludarabine or fludarabine phosphate...
- Patent number 5,668,270
- Issue date Sep 16, 1997
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of fludarabine or fludarabine phosphate...
- Patent number 5,602,246
- Issue date Feb 11, 1997
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-azido-2-fluoropurine, useful in the synthesis of nucleosides
- Patent number 5,180,824
- Issue date Jan 19, 1993
- Berlex Biosciences Inc.
- John G. Bauman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20240092745
- Publication date Mar 21, 2024
- Graybug Vision, Inc.
- Ming Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY
- Publication number 20210214374
- Publication date Jul 15, 2021
- Graybug Vision, Inc.
- John G. Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUGS TO TREAT OCULAR DISORDERS
- Publication number 20210040111
- Publication date Feb 11, 2021
- Graybug Vision, Inc.
- Ming Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY
- Publication number 20200308162
- Publication date Oct 1, 2020
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20200031783
- Publication date Jan 30, 2020
- Graybug Vision, Inc.
- Ming Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20190060474
- Publication date Feb 28, 2019
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20180110864
- Publication date Apr 26, 2018
- Graybug Vision, Inc.
- Jeffrey R. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20180104350
- Publication date Apr 19, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20180064823
- Publication date Mar 8, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20180036416
- Publication date Feb 8, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
- Publication number 20180028673
- Publication date Feb 1, 2018
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds And Compositions for the Treatment of Ocular Disorders
- Publication number 20170080092
- Publication date Mar 23, 2017
- Graybug Vision, Inc.
- Jeffrey L. Cleland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intermediates for the preparation of lipoxin A4 analogs
- Publication number 20070037864
- Publication date Feb 15, 2007
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20060135487
- Publication date Jun 22, 2006
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lipoxin A4 analogs
- Publication number 20040162433
- Publication date Aug 19, 2004
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20030158205
- Publication date Aug 21, 2003
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Lipoxin A4 analogs
- Publication number 20030139376
- Publication date Jul 24, 2003
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20030139425
- Publication date Jul 24, 2003
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20020177598
- Publication date Nov 28, 2002
- Schering Aktiengschellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY

John G. Bauman

Person

Patents Grantslast 30 patents

Drugs and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Compounds and compositions for the treatment of ocular disorders

Intermediates for the preparation of lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Process for the production of 2-fluoropurine derivatives

Process for the preparation of fludarabine or fludarabine phosphate...

Process for the preparation of fludarabine or fludarabine phosphate...

6-azido-2-fluoropurine, useful in the synthesis of nucleosides

Patents Applicationslast 30 patents

DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY

DRUGS TO TREAT OCULAR DISORDERS

DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY

DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

Compounds And Compositions for the Treatment of Ocular Disorders

Intermediates for the preparation of lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Lipoxin A4 analogs

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents